NCT05548504View on ClinicalTrials.gov

Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2029

Conditions
Non-small Cell Lung Cancer Stage IIIRadiotherapy Side EffectFrailty
Interventions
RADIATION

Photon

50-66Gy/ 24 fractions, inhomogeneous dose distribution photon therapy

RADIATION

Proton

50-66Gy/ 24 fractions, inhomogeneous dose distribution proton therapy

All Listed Sponsors
lead

Odense University Hospital

OTHER

NCT05548504 - Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC | Biotech Hunter | Biotech Hunter